EANM’16 – CTE Session VI
October 19, 2016, 08:00 – 09:30
Positron Emission Mammography
Chairpersons: P. Fragoso Costa (Oldenburg), A. Santos (Lisbon)
- Understand the physical and technical specifications of PEM scanners
- Get acquainted with the specificities involved with dedicated breast imaging and its consequences both in equipment design and daily practice
- Enumerate the different diagnostic solutions for breast cancer
- Identify the clinical advantages of PEM
- State the additional NMT competencies that are necessary to perform PEM
- Get acquainted with the clinical set up and the challenges for innovation when technologies are optimised to a very specific group
With the growing recognition of the large heterogeneity of breast cancer patients, breast cancer treatment is becoming increasingly individualized. This is one of the main motivations for considering new and alternatives for breast cancer diagnosis.
Molecular imaging exploits subtle differences in receptors or metabolic activity that distinguish tumour cells from adjacent normal tissue. While whole-body FDG- PET is an accepted method for restaging recurrent breast cancer and for assessing responses to chemotherapy for locally advanced breast cancer, the development of dedicated breast imaging devices promises to expand the role of molecular imaging in the detection and local staging of breast cancer.
This session will be divided in three parts; the first will explore the physical perspective of PEM, focusing on the challenges both in equipment design and detection effectiveness. Followed by an exposition of the clinical value of PEM. Finally the session will present the Technologist´s point of view, with practical examples and suggestions to those who envision or predict to be using this technology in the future.
Molecular Imaging, Breast Cancer, Multidisciplinary, Innovation